Zaiput’s Separators Sent to ISS to Understand Pharmaceutical Production

Zaiput’s gravity-independent liquid extraction technology will be tested in space. This will help to further our understanding of both terrestrial and extraterrestrial applications, particularly in pharmaceutical production.

Cambridge, MA (Zaiput Flow Technologies PR ) — As space travel and extraterrestrial habitation becomes a reality, it is becoming important to be able synthesize chemicals in space. Liquid separation is a key step in liquid extraction, one of the common steps in pharmaceutical production.

Unlike conventional technology, Zaiput’s liquid separators use surface forces, rather than gravity, making them potentially capable of separating liquids in space. Zaiput Flow Technologies announced that it will send its patented liquid separation technology to the International Space Station and test its applicability to drug development in microgavity.

Zaiput separators were launched from Cape Canaveral Air Force Station in Florida on the SpaceX Falcon 9 rocket as part of the CRS-13 Mission, a cargo resupply services mission to the International Space Station.

“Our separation technology is conceptually independent on the presence of gravity and therefore testing what exactly happens when there is no gravity is a great opportunity to learn more about our devices. We expect that the experiments on the space station will help us both improve terrestrial applications and enable extraterrestrial ones,” says Zaiput CEO and founder Andrea Adamo.

Zaiput previously won the Galactic Grant competition, a grant awarded by the Center for the Advancement of Science in Space (CASIS) that allows companies to test their technology in space. Zaiput has been working with Space Tango to properly box and prepare their products to be run and tested remotely. Zaiput’s separators are currently used by top pharmaceutical companies and academic laboratories worldwide but have never been tested in microgravity.

Zaiput Flow Technologies is an MIT spinoff that commercializes proprietary technology that enables continuous liquid-liquid separation for continuous chemical manufacturing (leveraged for pharmaceutical production). Zaiput is committed to the development and commercialization of innovative, high quality tools for the enhancement and growth of flow chemistry.